Urinary thromboxane B2 and thromboxane receptors in bladder cancer: Opportunity for detection and monitoring

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Becker, 2005, COX-2 inhibitors, Tex Heart Inst J, 32, 380 Buccoliero, 2004, Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance, Neuropathology, 24, 201, 10.1111/j.1440-1789.2004.00554.x Buccoliero, 2007, Cyclooxygenase-2 (COX-2) overexpression in meningiomas: real time PCR and immunohistochemistry, Appl Immunohistochem Mol Morphol, 15, 187, 10.1097/01.pai.0000201807.58801.fc Onguru, 2005, Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review, Endocr Pathol, 16, 253, 10.1385/EP:16:4:253 Castelao, 2000, Non-steroidal anti-inflammatory drugs and bladder cancer prevention, Br J Cancer, 82, 1364, 10.1054/bjoc.1999.1106 Moussa, 2005, Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer, Cancer Res, 65, 11581, 10.1158/0008-5472.CAN-05-1622 Moussa, 2004, Detection of chromosomal aberrations in transitional cell carcinoma of the bladder by representational difference analysis, Cancer Genomic Proteomic, 1, 9 Moussa, 2008, Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis, Cancer Res, 68, 4097, 10.1158/0008-5472.CAN-07-6560 Raychowdhury, 1994, Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor, J Biol Chem, 269, 19256, 10.1016/S0021-9258(17)32161-0 Mais, 1989, Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor, Biochim Biophys Acta, 1012, 184, 10.1016/0167-4889(89)90094-3 Wei, 2010, Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells, Lung Cancer, 69, 26, 10.1016/j.lungcan.2009.09.009 Turner, 2011, Identification of an Interaction between the TPα and TPβ isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK): implications for prostate cancer, J Biol Chem, 286, 15440, 10.1074/jbc.M110.181180 Dassesse, 2006, Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage, Eur Urol, 50, 1021, 10.1016/j.eururo.2006.01.036 Takahashi, 1996, Immunolocalization of rat thromboxane receptor in the kidney, Endocrinology, 137, 5170, 10.1210/en.137.11.5170 D’Angelo, 1996, Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP, Prostaglandins, 52, 303, 10.1016/S0090-6980(96)00091-3 Bresnahan, 1996, Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney, Kidney Int, 49, 1207, 10.1038/ki.1996.174 Rinder, 1994, Thromboxane A2 receptor blockade improves renal function and histopathology in the post-obstructive kidney, Kidney Int, 45, 185, 10.1038/ki.1994.22 Rump, 1989, Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney, Br J Pharmacol, 97, 819, 10.1111/j.1476-5381.1989.tb12021.x Endoh, 1997, Expression of thromboxane synthase in kidney tissues from patients with IgA nephropathy, Clin Nephrol, 47, 168 Kuzu, 1995, Thromboxane synthase inhibitor UK 38485, prevents renal injury in the rabbit isolated perfused kidney exposed to cold ischemia, Transplantation, 59, 1096, 10.1097/00007890-199504270-00004 Nusing, 1994, The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tu 300, Virchows Arch, 424, 69, 10.1007/BF00197395 Alessandrini, 1991, Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease, Adv Prostaglandin Thromboxane Leukot Res, 21B, 707